drugset
drugset / Trial / NCT04563559

PREFERENTIAL Study

NCT04563559 ↗

Phase 2/3 Withdrawn Duke University Ocular Therapeutix, Inc. · collab
NaSingle-groupOpen-labelTreatment

Summary

To determine patient preference for the dexamethasone insert or topical prednisolone therapy through at Day 45 as measured by - Modified COMTOL survey.

Timeline

Start
2020-11
Primary completion
2021-11
Completion
2021-11

Outcome

Outcome not reported

Stopped: “PI decided not to open study”

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.4 mg Other
Subject Prednisolone Other / unclassified 1 % Topical

Indications

cataract glaucoma